Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease

Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease
Front Pharmacol. 2021 Apr 15;12:650597. doi: 10.3389/fphar.2021.650597. eCollection 2021.ABSTRACTThis article discusses the role that melatonin may have in the prevention and treatment of Parkinson's disease (PD). In parkinsonian patients circulating melatonin levels are consistently disrupted and the potential therapeutic value of melatonin on sleep disorders in PD was examined in a limited number of clinical studies using 2-5 mg/day melatonin ... read more
Source: PubMedPublished on 2021-05-03By Santiago Pérez-Lloret